About
Physician-scientist joining Sofinnova's Crossover Strategy from the Roche Venture Fund, where he was Senior Investment Director. He has over 20 years of drug development and healthcare experience across Bristol Myers Squibb, Eli Lilly, Roche, the World Bank, and clinical practice, and will focus on late-stage private and public life-sciences investments.
Colleagues at Sofinnova Partners
Agnès Pauquet
Head of Human Resources at Sofinnova Partners
Ahmed Fourati
Investor Relations and Reporting Officer at Sofinnova Partners
Aishwarya Parthasarathy
Associate, Digital Medicine Strategy at Sofinnova Partners
Alex Leech
Partner, Biovelocita Strategy at Sofinnova Partners
Alexandra Abreu
Analyst, Crossover Strategy at Sofinnova Partners
Andrew M. Weiss
Venture Partner at Sofinnova Partners
Anis Belmili
Fund Accountant at Sofinnova Partners
Ankeet Jethwa
Senior Associate, Capital Strategy at Sofinnova Partners